Be among trailblazing marketing pros at Brandweek this September 23–26 in Phoenix, Arizona. Experience incredible networking, insightful sessions and a boost of inspiration at ADWEEK’s ultimate brand event. Register by May 13 to save 35%.
LOS ANGELES–Roster shops have received RFPs for Novartis AG’s $250 million global pharmaceutical products media consolidation review. The formal launch of the review had been expected this month [Adweek, July 9].
The RFP sets out a three-phase search that includes a project assignment and sets a September decision date, according to sources. Participating in the revivew are Novartis’ U.S. media shops MindShare and Optimedia, all New York, and Initiative Media North America in L.A. In addition, Creative Media in New York, whose sister network OMD handles some Novartis business overseas, and CIA, also a Novartis agency abroad, may be involved as well, sources said.
WORK SMARTER - LEARN, GROW AND BE INSPIRED.
Subscribe today!
To Read the Full Story Become an Adweek+ Subscriber
Already a member? Sign in